Literature DB >> 12663968

Abdominal aortic aneurysm size regression after endovascular repair is endograft dependent.

Daniel J Bertges1, Kira Chow, Mark C Wyers, Doug Landsittel, Anthony V Frydrych, William Stavropoulos, Walter A Tan, Robert Y Rhee, Mark F Fillinger, Ronald M Fairman, Michel S Makaroun.   

Abstract

OBJECTIVE: This study was performed to determine whether abdominal aortic aneurysm (AAA) regression is different with various endografts after endovascular repair.
METHODS: A four-center retrospective review of size change after endovascular AAA repair was performed. Consecutive patients with at least 1-year follow-up and available imaging studies were included. Three hundred ninety patients received either the Ancure, AneuRx, Excluder, or Talent endograft. AAA size and endoleak status were recorded from computed tomography (CT) scans at the initial postoperative follow-up visit and at 1 and 2 years thereafter. AAA size was defined as the minor axis of the infrarenal aorta on the largest axial section on the two-dimensional CT scan. A change in AAA size of 0.5 cm or greater from baseline was considered clinically significant. The effect of initial size, endoleak, and type of endograft on AAA regression was analyzed.
RESULTS: Mean baseline size was significantly greater with Talent endografts and smaller with Excluder endografts. Clinically significant regression in AAA size occurred in nearly three fourths of patients with Ancure and Talent endografts at 2 years. Regression in AAA size was less frequent with the AneuRx (46%) and Excluder (44%) devices. Initial size, endoleak, and endograft type were significant predictors of regression at multivariate analysis at 1 year. However, by 2 years only endograft type was still an independent predictor of AAA shrinkage.
CONCLUSIONS: Long-term morphologic changes after endovascular aneurysm repair depend on endograft type.

Entities:  

Mesh:

Year:  2003        PMID: 12663968     DOI: 10.1067/mva.2003.212

Source DB:  PubMed          Journal:  J Vasc Surg        ISSN: 0741-5214            Impact factor:   4.268


  8 in total

Review 1.  Mechanics, mechanobiology, and modeling of human abdominal aorta and aneurysms.

Authors:  J D Humphrey; G A Holzapfel
Journal:  J Biomech       Date:  2011-12-19       Impact factor: 2.712

2.  Factors affecting the regression of surgically replaced abdominal aortic aneurysms.

Authors:  Masahiro Matsushita; Teruo Ikezawa
Journal:  Surg Today       Date:  2006       Impact factor: 2.549

3.  Predictors and Consequences of Sac Shrinkage after Endovascular Infrarenal Aortic Aneurysm Repair.

Authors:  Sébastien Michel Vedani; Séverine Petitprez; Eva Weinz; Jean-Marc Corpataux; Sébastien Déglise; Céline Deslarzes-Dubuis; Elisabeth Côté; Jean-Baptiste Ricco; François Saucy
Journal:  J Clin Med       Date:  2022-06-06       Impact factor: 4.964

4.  Comparison of Endovascular Stent Grafts for Abdominal Aortic Aneurysm Repair in Medicare Beneficiaries.

Authors:  Dominique B Buck; Peter A Soden; Sarah E Deery; Sara L Zettervall; Klaas H J Ultee; Bruce E Landon; A James O'Malley; Marc L Schermerhorn
Journal:  Ann Vasc Surg       Date:  2017-09-08       Impact factor: 1.466

Review 5.  Intracranial and abdominal aortic aneurysms: similarities, differences, and need for a new class of computational models.

Authors:  J D Humphrey; C A Taylor
Journal:  Annu Rev Biomed Eng       Date:  2008       Impact factor: 9.590

6.  Endoleak following endovascular abdominal aortic aneurysm repair: implications for duration of screening.

Authors:  Matthew A Corriere; Irene D Feurer; Stacey Y Becker; Jeffery B Dattilo; Marc A Passman; Raul J Guzman; Thomas C Naslund
Journal:  Ann Surg       Date:  2004-06       Impact factor: 12.969

Review 7.  Endotension: twenty years of a controversial term.

Authors:  Álvaro Torres-Blanco; Manuel Miralles-Hernández
Journal:  CVIR Endovasc       Date:  2021-06-05

8.  Aneurysm pulsatility after endovascular exclusion--an experimental study using human aortic aneurysms.

Authors:  Hussein Amin Orra; Pedro Puech-Leão; Erasmo Simão da Silva; Domingos Guerino Silva
Journal:  Clinics (Sao Paulo)       Date:  2008-02       Impact factor: 2.365

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.